Evaluation of standardization parameter of polyherbal digestive “churna”

Authors

  • Abhishek Bhardwaj Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India
  • K. K. Jha Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India
  • A. Panka Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India
  • Anuj Agarwal Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India
  • Bhuvnesh Singh Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India
  • Neelanchal Trivedi Teerthankar Mahaveer College of Pharmacy, TMU, Moradabad, U.P. India

DOI:

https://doi.org/10.30750/ijpbr.5.2.8

Abstract

The development in these traditional systems of medicine leads to maintain proper quality of the product. India is rich in its flora and fauna. These plants are being used for curing many diseases as such in raw condition rather the being prepared as formulation. Churana is defined as a fine powder of drug or drugs in Ayurvedic system of medicine. Drugs mentioned in patha, are cleaned properly, dried thoroughly, pulverised and then sieved. The churana is free flowing and retains its potency for one year, if preserved in air tight containers. Churna formulations are similar to powder formulations in Allopathic system of medicine. In recent days churna is formulated into tablets in order to fix the dose easily. The churana was evaluated depending on various evaluation parameters and from the results obtained it was found to be within the standards. These preliminary tests can be prescribed as standards to fix the quality control test the churana and can be used in routine analysis of the same. The can also be used to perform quality control and quality assurance in the laboratory.

Downloads

Published

2017-06-30

How to Cite

1.
Bhardwaj A, Jha KK, Panka A, Agarwal A, Singh B, Trivedi N. Evaluation of standardization parameter of polyherbal digestive “churna”. IJPBR [Internet]. 2017Jun.30 [cited 2026Jul.30];5(02):39-44. Available from: https://ijpbr.in/index.php/IJPBR/article/view/671